US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ACRES Commercial Realty Corp.

18.79

+0.91005.09%

Post-market: 18.790.00000.00%16:10 EST

Volume:42.56K

Turnover:781.87K

Market Cap:136.90M

PE:19.70

High:19.06

Open:17.94

Low:17.78

Close:17.88

52wk High:24.61

52wk Low:16.51

Shares:7.29M

Float Shares:7.29M

Volume Ratio:1.42

T/O Rate:0.58%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.9538

EPS(LYR):1.15

ROE:7.03%

ROA:1.67%

PB:0.32

PE(LYR):16.34

Loading ...

Overview Company News Filings

ACRES Commercial Realty to Issue $879.5 Million in Debt Notes

MT Newswires Live

BRIEF-Acres Commercial Realty Corp. announces pricing of a $1.0 billion CLO backed by Commercial Mortgage Loans

Acres Commercial Realty Corp - to Issue $879.5 Mln Floating-Rate Notes

THOMSON REUTERS

Acres Commercial Realty Corp. Announces Pricing of a $1.0 Billion Clo Backed by Commercial Mortgage Loans

THOMSON REUTERS

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease

Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs

Focused Clinical Strategy and Accelerated Approval Path for ACR-368 in High-Need Serous Endometrial Cancer Underpin ACRV Buy Rating

Acrivon Highlights Promising ACR-368 Phase 2b Endometrial Data

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11

Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates via Webcast

TÜV Rheinland Reinforces Global Contamination Control with Clean Room Validation Services

Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates

Press Release: ACRES Commercial Realty Corp. Declares Quarterly Cash Dividends for its Preferred Stock

Novartis ianalumab significantly extends disease control in patients with immune thrombocytopenia with only four once-monthly doses

Antengene Hosts 2025 R&D Day Showcasing Encouraging Clinical Data and Solid Progress with Investigational Programs

Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates

Anaptys Announces Third Quarter 2025 Financial Results and Provides Business Update

ACRES Commercial Realty Corp. Reports Positive Q3 Earnings

Acres Commercial Realty Is Maintained at Market Outperform by Citizens

ACRES Commercial Realty Corp. price target raised to $24.50 from $23.50 at Citizens JMP

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ACR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACR\",,,,,undefined,":{"symbol":"ACR","market":"US","secType":"STK","nameCN":"ACRES Commercial Realty Corp.","latestPrice":18.79,"timestamp":1770411600000,"preClose":17.88,"halted":0,"volume":42564,"hourTrading":{"tag":"盘后","latestPrice":18.79,"preClose":18.79,"latestTime":"16:10 EST","volume":539,"amount":10127.81,"timestamp":1770412204679,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.050894854586129766,"floatShares":7285680,"shares":7285680,"eps":0.953836,"marketStatus":"Market Closed","change":0.91,"latestTime":"02-06 16:00:00 EST","open":17.94,"high":19.06,"low":17.78,"amount":781867.869307,"amplitude":0.071588,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.953836,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":17.88,"postHourTrading":{"tag":"盘后","latestPrice":18.79,"preClose":18.79,"latestTime":"16:10 EST","volume":539,"amount":10127.81,"timestamp":1770412204679,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.4164864045948378,"impliedVol":0.0493,"impliedVolPercentile":0.0916},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACR\",,,,,undefined,":{"symbol":"ACR","floatShares":7285680,"roa":"1.67%","roe":"7.03%","lyrEps":1.149999,"volumeRatio":1.4164864045948378,"shares":7285680,"dividePrice":0,"high":19.06,"amplitude":0.071588,"preClose":17.88,"low":17.78,"week52Low":16.51,"pbRate":"0.32","psRate":"1.54","week52High":24.61,"institutionHeld":0.2673,"latestPrice":18.79,"eps":0.953836,"divideRate":0,"volume":42564,"delay":0,"ttmEps":0.953836,"open":17.94,"prevYearClose":21.34,"prevWeekClose":19.15,"prevMonthClose":19.15,"prevQuarterClose":21.34,"fiveDayClose":19.15,"twentyDayClose":20.54,"sixtyDayClose":21.71,"dividendPayoutRate":1.1656236721746815,"dividendGrowthYears":0,"dividendGrowthRate":-0.7105263157894738,"fiveYearAvgDividendRate":0.07519862764902933},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACR\",params:#limit:5,,,undefined,":[{"date":"2025-10-29","symbol":"ACR","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":null,"defaultRemindTime":1761768000000,"name":null,"time":"Post Market","dateTimestamp":1761710400000,"actualEps":null},{"market":"US","date":"2025-07-30","symbol":"ACR","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"post","actualEps":-0.04},{"market":"US","date":"2025-04-30","symbol":"ACR","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1745985600000,"reportTimeType":"post","actualEps":-0.97},{"market":"US","date":"2025-03-05","symbol":"ACR","fiscalQuarterEnding":"2024/12","expectedEps":0.15,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741150800000,"reportTimeType":"post","actualEps":0.37},{"market":"US","date":"2024-10-30","symbol":"ACR","fiscalQuarterEnding":"2024/09","expectedEps":0.33,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730260800000,"reportTimeType":"post","actualEps":0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACR\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-29","recordDate":"2016-03-31","paymentDate":"2016-04-28","value":0.42,"currency":"USD"},{"executeDate":"2016-06-28","recordDate":"2016-06-30","paymentDate":"2016-07-28","value":0.42,"currency":"USD"},{"executeDate":"2016-09-28","recordDate":"2016-09-30","paymentDate":"2016-10-28","value":0.42,"currency":"USD"},{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-27","value":0.05,"currency":"USD"},{"executeDate":"2018-06-28","recordDate":"2018-06-29","paymentDate":"2018-07-27","value":0.1,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.3333,"hold":0.6667,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6667,"analysts":3,"updateTime":1765947600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACR","date":"2026-02-05","current":19.699403,"percent":0.476384,"low":-0.773314,"twenty":3.021298,"median":4.688572,"eighty":6.09596,"high":14.204017,"avg":4.809275,"sd":2.581779,"marketCap":131210792},"quantilePoints":[{"date":"2021-02-12","current":-0.601341,"twenty":-0.329791,"median":2.692411,"eighty":23.395443,"marketCap":129515022},{"date":"2021-02-19","current":-0.538901,"twenty":-0.336712,"median":2.68516,"eighty":23.382999,"marketCap":116066912},{"date":"2021-02-26","current":-0.585684,"twenty":-0.343632,"median":2.668242,"eighty":23.374703,"marketCap":126142837},{"date":"2021-03-05","current":-0.656758,"twenty":-0.34965,"median":2.65374,"eighty":23.37052,"marketCap":141450494},{"date":"2021-03-12","current":-0.765058,"twenty":-0.355066,"median":2.642864,"eighty":23.367731,"marketCap":151261945},{"date":"2021-03-19","current":-0.773314,"twenty":-0.359667,"median":2.636822,"eighty":23.366463,"marketCap":152894262},{"date":"2021-03-26","current":-0.730698,"twenty":-0.372029,"median":2.628363,"eighty":23.358624,"marketCap":144468510},{"date":"2021-04-01","current":-0.728783,"twenty":-0.374023,"median":2.619904,"eighty":23.353962,"marketCap":144089825},{"date":"2021-04-09","current":-0.733571,"twenty":-0.377896,"median":2.605403,"eighty":23.351176,"marketCap":145036538},{"date":"2021-04-16","current":-0.733507,"twenty":-0.38625,"median":2.600569,"eighty":23.341486,"marketCap":145023804},{"date":"2021-04-23","current":-0.728759,"twenty":-0.394383,"median":2.571519,"eighty":23.333221,"marketCap":144085138},{"date":"2021-04-30","current":-0.716127,"twenty":-0.403156,"median":2.562972,"eighty":23.333221,"marketCap":141587548},{"date":"2021-05-07","current":12.280556,"twenty":-0.403908,"median":2.564193,"eighty":23.325539,"marketCap":145696522},{"date":"2021-05-14","current":11.159187,"twenty":-0.403156,"median":2.571519,"eighty":23.313402,"marketCap":132392591},{"date":"2021-05-21","current":12.000214,"twenty":-0.401278,"median":2.600569,"eighty":23.309699,"marketCap":142370539},{"date":"2021-05-28","current":12.008001,"twenty":-0.399569,"median":2.605403,"eighty":23.297233,"marketCap":142462928},{"date":"2021-06-04","current":12.880178,"twenty":-0.397861,"median":2.619904,"eighty":23.282034,"marketCap":152810430},{"date":"2021-06-11","current":13.61997,"twenty":-0.394449,"median":2.629572,"eighty":23.269611,"marketCap":161587329},{"date":"2021-06-18","current":13.253968,"twenty":-0.393243,"median":2.638031,"eighty":23.261298,"marketCap":157245073},{"date":"2021-06-25","current":13.191669,"twenty":-0.389358,"median":2.644073,"eighty":23.248872,"marketCap":156505966},{"date":"2021-07-02","current":12.545324,"twenty":-0.388504,"median":2.655244,"eighty":23.240563,"marketCap":148837728},{"date":"2021-07-09","current":12.958051,"twenty":-0.387002,"median":2.668242,"eighty":23.229518,"marketCap":153734314},{"date":"2021-07-16","current":12.630985,"twenty":-0.385121,"median":2.68516,"eighty":23.229518,"marketCap":149854001},{"date":"2021-07-23","current":12.919114,"twenty":-0.385121,"median":2.696036,"eighty":23.229518,"marketCap":153272372},{"date":"2021-07-30","current":13.627758,"twenty":-0.378951,"median":2.704495,"eighty":23.222589,"marketCap":161679717},{"date":"2021-08-06","current":2.692645,"twenty":-0.378071,"median":2.712954,"eighty":23.210305,"marketCap":158604894},{"date":"2021-08-13","current":2.590862,"twenty":-0.377634,"median":2.699661,"eighty":23.201855,"marketCap":152609520},{"date":"2021-08-20","current":2.612452,"twenty":-0.375728,"median":2.692528,"eighty":23.188037,"marketCap":153881266},{"date":"2021-08-27","current":2.524548,"twenty":-0.374625,"median":2.68516,"eighty":23.18112,"marketCap":148703443},{"date":"2021-09-03","current":2.529174,"twenty":-0.374625,"median":2.668242,"eighty":23.18112,"marketCap":148975960},{"date":"2021-09-10","current":2.444355,"twenty":-0.373422,"median":2.655244,"eighty":23.164533,"marketCap":143979815},{"date":"2021-09-17","current":2.424306,"twenty":-0.373121,"median":2.644073,"eighty":23.160386,"marketCap":142798908},{"date":"2021-09-24","current":2.478282,"twenty":-0.372318,"median":2.638031,"eighty":23.160386,"marketCap":145978273},{"date":"2021-10-01","current":2.530717,"twenty":-0.372,"median":2.630356,"eighty":23.160386,"marketCap":149066799},{"date":"2021-10-08","current":2.432017,"twenty":-0.36928,"median":2.624738,"eighty":23.127211,"marketCap":143253103},{"date":"2021-10-15","current":2.422764,"twenty":-0.367258,"median":2.617487,"eighty":23.118917,"marketCap":142708069},{"date":"2021-10-22","current":2.422764,"twenty":-0.362252,"median":2.608928,"eighty":23.109059,"marketCap":142708069},{"date":"2021-10-29","current":2.421222,"twenty":-0.359194,"median":2.602389,"eighty":23.099865,"marketCap":142617230},{"date":"2021-11-05","current":2.948349,"twenty":-0.357001,"median":2.601479,"eighty":23.065008,"marketCap":135081545},{"date":"2021-11-12","current":2.972158,"twenty":-0.356571,"median":2.605403,"eighty":23.045624,"marketCap":136172379},{"date":"2021-11-19","current":2.906683,"twenty":-0.355367,"median":2.614969,"eighty":23.037354,"marketCap":133172587},{"date":"2021-11-26","current":2.84716,"twenty":-0.355066,"median":2.621242,"eighty":23.035979,"marketCap":130445503},{"date":"2021-12-03","current":2.698354,"twenty":-0.354164,"median":2.629572,"eighty":23.023539,"marketCap":123627794},{"date":"2021-12-10","current":2.672561,"twenty":-0.353562,"median":2.636203,"eighty":23.015245,"marketCap":122446058},{"date":"2021-12-17","current":2.432487,"twenty":-0.351757,"median":2.629572,"eighty":23.015245,"marketCap":111446820},{"date":"2021-12-23","current":2.45828,"twenty":-0.349951,"median":2.622321,"eighty":23.001399,"marketCap":112628556},{"date":"2021-12-31","current":2.474153,"twenty":-0.348446,"median":2.614969,"eighty":22.97803,"marketCap":113355779},{"date":"2022-01-07","current":2.45828,"twenty":-0.34634,"median":2.605403,"eighty":22.973988,"marketCap":112628556},{"date":"2022-01-14","current":2.628911,"twenty":-0.344535,"median":2.605403,"eighty":22.973776,"marketCap":120446196},{"date":"2022-01-21","current":2.41463,"twenty":-0.344234,"median":2.601479,"eighty":22.969629,"marketCap":110628695},{"date":"2022-01-28","current":2.329315,"twenty":-0.342428,"median":2.593946,"eighty":22.948894,"marketCap":106719875},{"date":"2022-02-04","current":2.416614,"twenty":-0.33972,"median":2.588548,"eighty":22.928309,"marketCap":110719598},{"date":"2022-02-11","current":2.402726,"twenty":-0.338517,"median":2.584693,"eighty":22.90988,"marketCap":110083278},{"date":"2022-02-18","current":2.333283,"twenty":-0.337915,"median":2.570395,"eighty":22.898273,"marketCap":106901681},{"date":"2022-02-25","current":2.245983,"twenty":-0.335508,"median":2.564193,"eighty":22.890838,"marketCap":102901958},{"date":"2022-03-04","current":3.243244,"twenty":-0.330994,"median":2.564193,"eighty":22.871107,"marketCap":110020560},{"date":"2022-03-11","current":3.039484,"twenty":-0.330994,"median":2.570395,"eighty":22.849369,"marketCap":103108427},{"date":"2022-03-18","current":3.155514,"twenty":-0.32949,"median":2.584693,"eighty":22.828635,"marketCap":107044517},{"date":"2022-03-25","current":3.422888,"twenty":-0.32949,"median":2.588548,"eighty":22.828635,"marketCap":116114636},{"date":"2022-04-01","current":3.397664,"twenty":-0.328951,"median":2.593946,"eighty":22.827656,"marketCap":115258964},{"date":"2022-04-08","current":3.274067,"twenty":-0.327985,"median":2.601479,"eighty":22.8079,"marketCap":111066173},{"date":"2022-04-14","current":3.248843,"twenty":-0.327985,"median":2.605403,"eighty":22.791313,"marketCap":110210502},{"date":"2022-04-22","current":3.127915,"twenty":-0.327985,"median":2.612452,"eighty":22.72819,"marketCap":106108277},{"date":"2022-04-29","current":2.868089,"twenty":-0.326782,"median":2.621242,"eighty":22.688706,"marketCap":97294170},{"date":"2022-05-06","current":4.375842,"twenty":-0.326481,"median":2.628911,"eighty":22.657479,"marketCap":100429958},{"date":"2022-05-13","current":4.21343,"twenty":-0.325277,"median":2.630625,"eighty":22.634624,"marketCap":96702425},{"date":"2022-05-20","current":3.735933,"twenty":-0.322569,"median":2.636822,"eighty":22.60654,"marketCap":85743401},{"date":"2022-05-27","current":3.743573,"twenty":-0.321967,"median":2.642864,"eighty":22.591302,"marketCap":85918746},{"date":"2022-06-03","current":3.785593,"twenty":-0.321967,"median":2.651324,"eighty":22.545587,"marketCap":86883140},{"date":"2022-06-10","current":3.678634,"twenty":-0.321692,"median":2.668242,"eighty":22.48538,"marketCap":84428318},{"date":"2022-06-17","current":3.224057,"twenty":-0.320881,"median":2.67161,"eighty":22.421163,"marketCap":73995328},{"date":"2022-06-24","current":3.193497,"twenty":-0.319259,"median":2.686797,"eighty":22.367371,"marketCap":73293950},{"date":"2022-07-01","current":3.304276,"twenty":-0.317289,"median":2.691936,"eighty":22.325763,"marketCap":75836444},{"date":"2022-07-08","current":3.227877,"twenty":-0.316825,"median":2.692645,"eighty":22.317329,"marketCap":74083000},{"date":"2022-07-15","current":2.998678,"twenty":-0.315949,"median":2.699661,"eighty":22.30517,"marketCap":68822669},{"date":"2022-07-22","current":3.055978,"twenty":-0.315949,"median":2.704495,"eighty":22.284437,"marketCap":70137752},{"date":"2022-07-29","current":3.174397,"twenty":-0.315648,"median":2.716828,"eighty":22.263703,"marketCap":72855589},{"date":"2022-08-05","current":5.232925,"twenty":-0.314444,"median":2.726247,"eighty":22.238823,"marketCap":77625212},{"date":"2022-08-12","current":5.466621,"twenty":-0.314444,"median":2.760853,"eighty":22.205649,"marketCap":81091851},{"date":"2022-08-19","current":5.438471,"twenty":-0.312338,"median":2.772168,"eighty":22.201502,"marketCap":80674282},{"date":"2022-08-26","current":5.815674,"twenty":-0.303913,"median":2.785945,"eighty":22.182759,"marketCap":86269703},{"date":"2022-09-02","current":5.460991,"twenty":-0.303612,"median":2.798754,"eighty":22.174132,"marketCap":81008337},{"date":"2022-09-09","current":5.427211,"twenty":-0.302408,"median":2.815672,"eighty":22.174132,"marketCap":80507255},{"date":"2022-09-16","current":5.179496,"twenty":-0.300904,"median":2.822922,"eighty":22.164182,"marketCap":76832650},{"date":"2022-09-23","current":4.898002,"twenty":-0.300904,"median":2.831036,"eighty":22.164182,"marketCap":72656962},{"date":"2022-09-30","current":4.588358,"twenty":-0.300904,"median":2.842292,"eighty":22.164182,"marketCap":68063706},{"date":"2022-10-07","current":4.802294,"twenty":-0.300904,"median":2.861593,"eighty":22.122715,"marketCap":71237228},{"date":"2022-10-14","current":4.644657,"twenty":-0.300904,"median":2.866049,"eighty":22.122715,"marketCap":68898843},{"date":"2022-10-21","current":4.802294,"twenty":-0.299399,"median":2.878511,"eighty":22.101982,"marketCap":71237228},{"date":"2022-10-28","current":5.731225,"twenty":-0.297895,"median":2.885762,"eighty":22.101982,"marketCap":85016997},{"date":"2022-11-04","current":5.658037,"twenty":-0.294886,"median":2.890595,"eighty":22.081248,"marketCap":83931318},{"date":"2022-11-11","current":3.269547,"twenty":-0.287363,"median":2.891803,"eighty":22.060514,"marketCap":82896095},{"date":"2022-11-18","current":3.224437,"twenty":-0.28285,"median":2.893012,"eighty":22.039781,"marketCap":81752380},{"date":"2022-11-25","current":3.264743,"twenty":-0.281646,"median":2.900263,"eighty":22.039781,"marketCap":82774284},{"date":"2022-12-02","current":3.208315,"twenty":-0.278938,"median":2.909515,"eighty":22.039781,"marketCap":81343618},{"date":"2022-12-09","current":3.027746,"twenty":0.690334,"median":2.920572,"eighty":22.023194,"marketCap":76765484},{"date":"2022-12-16","current":2.937462,"twenty":1.319576,"median":2.928984,"eighty":21.985873,"marketCap":74476418},{"date":"2022-12-23","current":2.498939,"twenty":1.458571,"median":2.923052,"eighty":21.878059,"marketCap":63358094},{"date":"2022-12-30","current":2.663385,"twenty":1.56152,"median":2.918116,"eighty":21.803418,"marketCap":67527465},{"date":"2023-01-06","current":2.889096,"twenty":1.56152,"median":2.920572,"eighty":21.803418,"marketCap":73250132},{"date":"2023-01-13","current":3.121255,"twenty":1.56152,"median":2.934238,"eighty":21.803418,"marketCap":79136303},{"date":"2023-01-20","current":3.163173,"twenty":1.56152,"median":2.940687,"eighty":21.803418,"marketCap":80199084},{"date":"2023-01-27","current":3.03742,"twenty":1.56152,"median":2.963813,"eighty":21.803418,"marketCap":77010741},{"date":"2023-02-03","current":3.089011,"twenty":1.56152,"median":2.97938,"eighty":21.803418,"marketCap":78318780},{"date":"2023-02-10","current":2.995502,"twenty":1.56152,"median":2.986046,"eighty":21.803418,"marketCap":75947961},{"date":"2023-02-17","current":3.069664,"twenty":1.56152,"median":2.995967,"eighty":21.803418,"marketCap":77828265},{"date":"2023-02-24","current":3.101909,"twenty":1.56152,"median":3.006318,"eighty":21.803418,"marketCap":78645789},{"date":"2023-03-03","current":7.166438,"twenty":1.56152,"median":3.021298,"eighty":21.803418,"marketCap":76129066},{"date":"2023-03-10","current":6.673589,"twenty":1.565877,"median":3.03742,"eighty":21.803418,"marketCap":70893541},{"date":"2023-03-17","current":6.627828,"twenty":1.596379,"median":3.047969,"eighty":21.803418,"marketCap":70407414},{"date":"2023-03-24","current":7.581198,"twenty":1.601086,"median":3.061417,"eighty":21.803418,"marketCap":80535062},{"date":"2023-03-31","current":7.413404,"twenty":1.645072,"median":3.077506,"eighty":21.786831,"marketCap":78752596},{"date":"2023-04-06","current":7.192223,"twenty":1.601086,"median":3.08741,"eighty":21.803418,"marketCap":76402982},{"date":"2023-04-14","current":7.390524,"twenty":1.5571,"median":3.105133,"eighty":21.820005,"marketCap":78509533},{"date":"2023-04-21","current":7.375972,"twenty":1.513114,"median":3.121255,"eighty":21.836592,"marketCap":78354950},{"date":"2023-04-28","current":6.610326,"twenty":1.469128,"median":3.128557,"eighty":21.853179,"marketCap":70221497},{"date":"2023-05-05","current":6.094842,"twenty":1.469128,"median":3.146532,"eighty":21.853179,"marketCap":64745508},{"date":"2023-05-12","current":6.315875,"twenty":1.469128,"median":3.161027,"eighty":21.853179,"marketCap":69335675},{"date":"2023-05-19","current":6.24252,"twenty":1.469128,"median":3.171711,"eighty":21.853179,"marketCap":68530383},{"date":"2023-05-26","current":5.892774,"twenty":1.469128,"median":3.174891,"eighty":21.853179,"marketCap":64690871},{"date":"2023-06-02","current":6.111565,"twenty":1.469128,"median":3.178756,"eighty":21.853179,"marketCap":67092760},{"date":"2023-06-09","current":6.149999,"twenty":1.469128,"median":3.189323,"eighty":21.853179,"marketCap":67514692},{"date":"2023-06-16","current":6.082393,"twenty":1.469128,"median":3.199227,"eighty":21.853179,"marketCap":66772508},{"date":"2023-06-23","current":6.049574,"twenty":1.458571,"median":3.208315,"eighty":21.878059,"marketCap":66412225},{"date":"2023-06-30","current":6.257426,"twenty":1.448015,"median":3.216397,"eighty":21.902939,"marketCap":68694019},{"date":"2023-07-07","current":6.250133,"twenty":1.448015,"median":3.224292,"eighty":21.902939,"marketCap":68613956},{"date":"2023-07-14","current":6.578319,"twenty":1.448015,"median":3.243521,"eighty":21.902939,"marketCap":72216789},{"date":"2023-07-21","current":6.702301,"twenty":1.448015,"median":3.24834,"eighty":21.902939,"marketCap":73577860},{"date":"2023-07-28","current":6.578319,"twenty":1.448015,"median":3.264991,"eighty":21.902939,"marketCap":72216789},{"date":"2023-08-04","current":6.184495,"twenty":1.448015,"median":3.286333,"eighty":21.902939,"marketCap":67893390},{"date":"2023-08-11","current":6.351685,"twenty":1.448015,"median":3.322273,"eighty":21.902939,"marketCap":70535467},{"date":"2023-08-18","current":6.122833,"twenty":1.448015,"median":3.390097,"eighty":21.902939,"marketCap":67994059},{"date":"2023-08-25","current":6.050115,"twenty":1.448015,"median":3.429194,"eighty":21.902939,"marketCap":67186529},{"date":"2023-09-01","current":6.166463,"twenty":1.448015,"median":3.730203,"eighty":21.902939,"marketCap":68478577},{"date":"2023-09-08","current":5.810147,"twenty":1.448015,"median":3.743573,"eighty":21.902939,"marketCap":64521678},{"date":"2023-09-15","current":6.006485,"twenty":1.448015,"median":3.764583,"eighty":21.902939,"marketCap":66702011},{"date":"2023-09-22","current":5.868321,"twenty":1.448015,"median":4.024697,"eighty":21.902939,"marketCap":65167703},{"date":"2023-09-29","current":5.991941,"twenty":1.448015,"median":4.078921,"eighty":21.902939,"marketCap":66540504},{"date":"2023-10-06","current":5.970126,"twenty":1.448015,"median":4.113063,"eighty":21.902939,"marketCap":66298245},{"date":"2023-10-13","current":5.82469,"twenty":1.448015,"median":4.135155,"eighty":21.902939,"marketCap":64683185},{"date":"2023-10-20","current":5.263018,"twenty":1.448015,"median":4.142325,"eighty":21.902939,"marketCap":58445820},{"date":"2023-10-27","current":5.453103,"twenty":1.416345,"median":4.14118,"eighty":21.97758,"marketCap":60556704},{"date":"2023-11-03","current":5.639187,"twenty":1.416345,"median":4.14118,"eighty":14.071633,"marketCap":62623174},{"date":"2023-11-10","current":4.597236,"twenty":1.416345,"median":4.14118,"eighty":13.99376,"marketCap":60968545},{"date":"2023-11-17","current":4.691483,"twenty":1.416345,"median":4.14118,"eighty":13.99376,"marketCap":62218453},{"date":"2023-11-24","current":4.594442,"twenty":1.416345,"median":4.14118,"eighty":13.99376,"marketCap":60931496},{"date":"2023-12-01","current":4.552014,"twenty":1.416345,"median":4.14118,"eighty":13.99376,"marketCap":60368804},{"date":"2023-12-08","current":5.091467,"twenty":1.426902,"median":4.14118,"eighty":13.959496,"marketCap":67523030},{"date":"2023-12-15","current":5.430898,"twenty":1.426902,"median":4.14118,"eighty":13.959496,"marketCap":72024565},{"date":"2023-12-22","current":6.121882,"twenty":1.426902,"median":4.144334,"eighty":13.959496,"marketCap":81188405},{"date":"2023-12-29","current":5.921861,"twenty":1.416345,"median":4.173313,"eighty":13.99376,"marketCap":78535715},{"date":"2024-01-05","current":5.994596,"twenty":1.319576,"median":4.201799,"eighty":14.009335,"marketCap":79500329},{"date":"2024-01-12","current":6.030963,"twenty":1.319576,"median":4.247621,"eighty":14.009335,"marketCap":79982637},{"date":"2024-01-19","current":5.897615,"twenty":1.222807,"median":4.282189,"eighty":14.024909,"marketCap":78214176},{"date":"2024-01-26","current":5.909738,"twenty":1.319576,"median":4.311888,"eighty":14.009335,"marketCap":78374946},{"date":"2024-02-02","current":6.079454,"twenty":1.319576,"median":4.327955,"eighty":14.009335,"marketCap":80625713},{"date":"2024-02-09","current":5.976412,"twenty":1.319576,"median":4.350046,"eighty":14.009335,"marketCap":79259176},{"date":"2024-02-16","current":6.085515,"twenty":1.319576,"median":4.362096,"eighty":14.009335,"marketCap":80706098},{"date":"2024-02-23","current":6.321904,"twenty":1.319576,"median":4.386196,"eighty":14.009335,"marketCap":83841096},{"date":"2024-03-01","current":6.697703,"twenty":1.416345,"median":4.576259,"eighty":13.99376,"marketCap":88824938},{"date":"2024-03-08","current":3.802021,"twenty":1.416345,"median":4.594442,"eighty":13.99376,"marketCap":85127249},{"date":"2024-03-15","current":3.670771,"twenty":1.416345,"median":4.552014,"eighty":13.627758,"marketCap":82188558},{"date":"2024-03-22","current":4.518879,"twenty":1.416345,"median":4.374799,"eighty":13.542097,"marketCap":101177708},{"date":"2024-03-28","current":4.473036,"twenty":1.416345,"median":4.324209,"eighty":13.253968,"marketCap":100151267},{"date":"2024-04-05","current":4.548166,"twenty":1.319576,"median":4.316791,"eighty":13.048383,"marketCap":101833436},{"date":"2024-04-12","current":4.421557,"twenty":1.319576,"median":4.316791,"eighty":12.951821,"marketCap":98998672},{"date":"2024-04-19","current":4.434543,"twenty":1.319576,"median":4.316791,"eighty":12.824109,"marketCap":99289417},{"date":"2024-04-26","current":4.434543,"twenty":1.416345,"median":4.324209,"eighty":12.732219,"marketCap":99289417},{"date":"2024-05-03","current":4.212125,"twenty":1.416345,"median":4.309328,"eighty":12.514175,"marketCap":94309475},{"date":"2024-05-10","current":3.932803,"twenty":1.416345,"median":4.212125,"eighty":12.280556,"marketCap":98662220},{"date":"2024-05-17","current":3.918344,"twenty":1.416345,"median":4.14347,"eighty":12.078087,"marketCap":98299491},{"date":"2024-05-24","current":3.756405,"twenty":1.416345,"median":3.988402,"eighty":12.000214,"marketCap":94236929},{"date":"2024-05-31","current":3.606033,"twenty":1.416345,"median":3.918344,"eighty":11.314932,"marketCap":90464550},{"date":"2024-06-07","current":3.788005,"twenty":1.416345,"median":3.860508,"eighty":9.717873,"marketCap":95029691},{"date":"2024-06-14","current":3.851139,"twenty":1.319576,"median":3.804358,"eighty":7.887548,"marketCap":96613519},{"date":"2024-06-21","current":3.893228,"twenty":1.222807,"median":3.802673,"eighty":7.521707,"marketCap":97669405},{"date":"2024-06-28","current":3.839113,"twenty":0.932501,"median":3.800901,"eighty":7.413404,"marketCap":96311838},{"date":"2024-07-05","current":3.953355,"twenty":0.932501,"median":3.800901,"eighty":7.375972,"marketCap":99177812},{"date":"2024-07-12","current":4.109685,"twenty":0.932501,"median":3.800901,"eighty":7.207477,"marketCap":103099673},{"date":"2024-07-15","current":4.193863,"twenty":0.932501,"median":3.800901,"eighty":7.194036,"marketCap":105211444},{"date":"2024-08-02","current":4.458422,"twenty":-0.282248,"median":3.785593,"eighty":6.893892,"marketCap":111848438},{"date":"2024-08-09","current":4.330188,"twenty":-0.282248,"median":3.785593,"eighty":6.71397,"marketCap":112034952},{"date":"2024-08-16","current":4.293515,"twenty":-0.282248,"median":3.785593,"eighty":6.684421,"marketCap":111086122},{"date":"2024-08-23","current":4.437385,"twenty":-0.282248,"median":3.785593,"eighty":6.626684,"marketCap":114808456},{"date":"2024-08-30","current":4.443027,"twenty":-0.282248,"median":3.785593,"eighty":6.593741,"marketCap":114954430},{"date":"2024-09-06","current":4.420459,"twenty":-0.282248,"median":3.785593,"eighty":6.572485,"marketCap":114370534},{"date":"2024-09-13","current":4.358398,"twenty":-0.282248,"median":3.785593,"eighty":6.489344,"marketCap":112764822},{"date":"2024-09-20","current":4.358398,"twenty":-0.282248,"median":3.785593,"eighty":6.439122,"marketCap":112764822},{"date":"2024-09-27","current":4.403533,"twenty":-0.282248,"median":3.785593,"eighty":6.403286,"marketCap":113932613},{"date":"2024-10-04","current":4.45149,"twenty":-0.282248,"median":3.785593,"eighty":6.389947,"marketCap":115173391},{"date":"2024-10-11","current":4.474057,"twenty":-0.282248,"median":3.785593,"eighty":6.366105,"marketCap":115757286},{"date":"2024-10-18","current":4.327367,"twenty":-0.282248,"median":3.785593,"eighty":6.321904,"marketCap":111961965},{"date":"2024-10-25","current":4.321725,"twenty":-0.282248,"median":3.785593,"eighty":6.261802,"marketCap":111815992},{"date":"2024-10-31","current":4.27941,"twenty":-0.282248,"median":3.785593,"eighty":6.240491,"marketCap":110721187},{"date":"2024-11-08","current":4.441959,"twenty":-0.282549,"median":3.784012,"eighty":6.202291,"marketCap":116779104},{"date":"2024-11-15","current":4.397133,"twenty":-0.282549,"median":3.784012,"eighty":6.149605,"marketCap":115600635},{"date":"2024-11-22","current":4.560596,"twenty":-0.282549,"median":3.784012,"eighty":6.139391,"marketCap":119898057},{"date":"2024-11-29","current":4.732231,"twenty":-0.282549,"median":3.784012,"eighty":6.120618,"marketCap":124410349},{"date":"2024-12-06","current":4.80034,"twenty":-0.282549,"median":3.784012,"eighty":6.102487,"marketCap":126200941},{"date":"2024-12-13","current":4.66957,"twenty":-0.282549,"median":3.784012,"eighty":6.088852,"marketCap":122763004},{"date":"2024-12-20","current":4.171011,"twenty":-0.282549,"median":3.784012,"eighty":6.078382,"marketCap":109655869},{"date":"2024-12-27","current":4.405306,"twenty":-0.282549,"median":3.784012,"eighty":6.067331,"marketCap":115815506},{"date":"2025-01-03","current":4.489762,"twenty":-0.282549,"median":3.784012,"eighty":6.059453,"marketCap":118035841},{"date":"2025-01-10","current":4.745853,"twenty":-0.28285,"median":3.782431,"eighty":6.049147,"marketCap":124768467},{"date":"2025-01-17","current":4.822135,"twenty":-0.28285,"median":3.782431,"eighty":6.037025,"marketCap":126773931},{"date":"2025-01-24","current":4.890244,"twenty":-0.28285,"median":3.782431,"eighty":6.035572,"marketCap":128564523},{"date":"2025-01-31","current":4.794891,"twenty":-0.28285,"median":3.782431,"eighty":6.016756,"marketCap":126057694},{"date":"2025-02-07","current":5.012841,"twenty":-0.28285,"median":3.782431,"eighty":6.002169,"marketCap":131787589},{"date":"2025-02-14","current":5.165406,"twenty":-0.28285,"median":3.782431,"eighty":5.999213,"marketCap":135798516},{"date":"2025-02-21","current":5.375182,"twenty":-0.28285,"median":3.782431,"eighty":5.991941,"marketCap":141313540},{"date":"2025-02-28","current":5.6231,"twenty":-0.28285,"median":3.782431,"eighty":5.970126,"marketCap":147831296},{"date":"2025-03-07","current":5.080493,"twenty":-0.283753,"median":3.782268,"eighty":5.951081,"marketCap":148690780},{"date":"2025-03-14","current":5.481842,"twenty":-0.283753,"median":3.782268,"eighty":5.922788,"marketCap":160437065},{"date":"2025-03-21","current":11.366901,"twenty":-0.283753,"median":3.788005,"eighty":5.926495,"marketCap":332675095},{"date":"2025-03-28","current":5.041233,"twenty":-0.283753,"median":3.800901,"eighty":5.92678,"marketCap":147541761},{"date":"2025-04-04","current":4.869586,"twenty":-0.283753,"median":3.829511,"eighty":5.92678,"marketCap":142518184},{"date":"2025-04-11","current":4.150082,"twenty":-0.28285,"median":3.860508,"eighty":5.926495,"marketCap":121460451},{"date":"2025-04-17","current":4.12892,"twenty":-0.28285,"median":3.878196,"eighty":5.926495,"marketCap":120841106},{"date":"2025-04-25","current":4.180649,"twenty":-0.283753,"median":3.918344,"eighty":5.92678,"marketCap":122355061},{"date":"2025-05-02","current":5.432928,"twenty":-0.283753,"median":3.947302,"eighty":5.92678,"marketCap":128135615},{"date":"2025-05-09","current":5.37749,"twenty":-0.281646,"median":3.98112,"eighty":5.92678,"marketCap":126828109},{"date":"2025-05-16","current":5.476695,"twenty":2.250745,"median":4.028927,"eighty":5.92678,"marketCap":129167857},{"date":"2025-05-23","current":5.249107,"twenty":2.332489,"median":4.112248,"eighty":5.92678,"marketCap":123800199},{"date":"2025-05-30","current":5.567147,"twenty":2.374551,"median":4.140676,"eighty":5.92678,"marketCap":131301156},{"date":"2025-06-06","current":5.307463,"twenty":2.40471,"median":4.185579,"eighty":5.92678,"marketCap":125176522},{"date":"2025-06-13","current":5.224981,"twenty":2.416202,"median":4.205138,"eighty":5.92678,"marketCap":123231183},{"date":"2025-06-20","current":5.158476,"twenty":2.41849,"median":4.272609,"eighty":5.927066,"marketCap":121662663},{"date":"2025-06-27","current":4.984985,"twenty":2.422764,"median":4.287873,"eighty":5.927066,"marketCap":117570869},{"date":"2025-07-03","current":5.25968,"twenty":2.428519,"median":4.304505,"eighty":5.927066,"marketCap":124049542},{"date":"2025-07-11","current":5.175825,"twenty":2.4314,"median":4.313262,"eighty":5.927066,"marketCap":122071842},{"date":"2025-07-18","current":5.10932,"twenty":2.435775,"median":4.324546,"eighty":5.927066,"marketCap":120503321},{"date":"2025-07-25","current":5.476544,"twenty":2.441952,"median":4.330188,"eighty":5.927066,"marketCap":129164284},{"date":"2025-08-01","current":5.690516,"twenty":2.44528,"median":4.348095,"eighty":5.927066,"marketCap":134210830},{"date":"2025-08-08","current":12.38965,"twenty":2.450451,"median":4.358398,"eighty":5.954591,"marketCap":268558053},{"date":"2025-08-15","current":6.486713,"twenty":2.458262,"median":4.36404,"eighty":5.97264,"marketCap":140605991},{"date":"2025-08-22","current":6.679906,"twenty":2.465491,"median":4.368755,"eighty":5.994708,"marketCap":144793651},{"date":"2025-08-29","current":6.810885,"twenty":2.470572,"median":4.375842,"eighty":6.000657,"marketCap":147632742},{"date":"2025-09-05","current":6.987706,"twenty":2.483034,"median":4.398496,"eighty":6.006485,"marketCap":151465515},{"date":"2025-09-12","current":6.928766,"twenty":2.495068,"median":4.409175,"eighty":6.022625,"marketCap":150187924},{"date":"2025-09-19","current":6.941863,"twenty":2.500798,"median":4.419175,"eighty":6.035572,"marketCap":150471833},{"date":"2025-09-26","current":6.90257,"twenty":2.527324,"median":4.421557,"eighty":6.043513,"marketCap":149620106},{"date":"2025-10-03","current":6.745396,"twenty":2.532032,"median":4.434543,"eighty":6.051357,"marketCap":146213196},{"date":"2025-10-10","current":6.722474,"twenty":2.556317,"median":4.437385,"eighty":6.065728,"marketCap":145716355},{"date":"2025-10-17","current":6.643887,"twenty":2.585618,"median":4.445848,"eighty":6.0751,"marketCap":144012901},{"date":"2025-10-24","current":6.309892,"twenty":2.604655,"median":4.45149,"eighty":6.083642,"marketCap":136773218},{"date":"2025-10-31","current":6.810885,"twenty":2.630101,"median":4.459953,"eighty":6.09596,"marketCap":147632742},{"date":"2025-11-07","current":5.39737,"twenty":2.688434,"median":4.473036,"eighty":6.09596,"marketCap":154375584},{"date":"2025-11-14","current":5.219888,"twenty":2.710757,"median":4.479992,"eighty":6.09596,"marketCap":149299237},{"date":"2025-11-21","current":4.811248,"twenty":2.777321,"median":4.499446,"eighty":6.09596,"marketCap":137611319},{"date":"2025-11-28","current":5.159078,"twenty":2.84071,"median":4.527769,"eighty":6.09596,"marketCap":147559963},{"date":"2025-12-05","current":5.587177,"twenty":2.880693,"median":4.548166,"eighty":6.09596,"marketCap":159804449},{"date":"2025-12-12","current":5.764741,"twenty":2.92206,"median":4.56332,"eighty":6.09596,"marketCap":164883127},{"date":"2025-12-19","current":5.847442,"twenty":2.937055,"median":4.577383,"eighty":6.09596,"marketCap":167248539},{"date":"2025-12-26","current":5.395019,"twenty":2.947864,"median":4.593615,"eighty":6.09596,"marketCap":154308344},{"date":"2026-01-02","current":5.190699,"twenty":2.963319,"median":4.604018,"eighty":6.09596,"marketCap":148464385},{"date":"2026-01-09","current":4.996109,"twenty":2.976523,"median":4.634154,"eighty":6.09596,"marketCap":142898710},{"date":"2026-01-16","current":5.008271,"twenty":2.989785,"median":4.666846,"eighty":6.09596,"marketCap":143246565},{"date":"2026-01-23","current":4.896381,"twenty":2.995781,"median":4.677743,"eighty":6.09596,"marketCap":140046302},{"date":"2026-01-30","current":4.748006,"twenty":3.010469,"median":4.688572,"eighty":6.09596,"marketCap":135802474},{"date":"2026-02-05","current":4.587469,"twenty":3.021298,"median":4.688572,"eighty":6.09596,"marketCap":131210792}],"updateTime":1770439327040},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2605987174","title":"ACRES Commercial Realty to Issue $879.5 Million in Debt Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2605987174","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605987174?lang=en_us&edition=fundamental","pubTime":"2026-01-21 16:36","pubTimestamp":1768984580,"startTime":"0","endTime":"0","summary":"ACRES Commercial Realty  said Tuesday that it will issue through a subsidiary $879.5 million in non-recourse, floating-rate notes at a weighted-average cost of the one-month term secured overnight financing rate plus 168 basis points.The transaction is expected to close by Feb. 12.The notes are collateralized by around $1 billion of floating-rate first mortgage loans originated by the company and $200 million in cash, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","ACR","ACR.AU","BK7096","BK4110"],"gpt_icon":0},{"id":"2605140244","title":"BRIEF-Acres Commercial Realty Corp. announces pricing of a $1.0 billion CLO backed by Commercial Mortgage Loans","url":"https://stock-news.laohu8.com/highlight/detail?id=2605140244","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605140244?lang=en_us&edition=fundamental","pubTime":"2026-01-21 08:07","pubTimestamp":1768954060,"startTime":"0","endTime":"0","summary":"BRIEF-Acres Commercial Realty Corp. announces pricing of a $1.0 billion CLO backed by Commercial Mortgage LoansJan 20 (Reuters) - Acres Commercial Realty Corp ACR.N:ACRES COMMERCIAL REALTY CORP. ANNOU","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nFWN3YL1A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4110","ACR"],"gpt_icon":0},{"id":"2605298140","title":"Acres Commercial Realty Corp - to Issue $879.5 Mln Floating-Rate Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2605298140","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605298140?lang=en_us&edition=fundamental","pubTime":"2026-01-21 08:04","pubTimestamp":1768953887,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nFWN3YL1A0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACR","BK4110"],"gpt_icon":0},{"id":"2605140477","title":"Acres Commercial Realty Corp. Announces Pricing of a $1.0 Billion Clo Backed by Commercial Mortgage Loans","url":"https://stock-news.laohu8.com/highlight/detail?id=2605140477","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605140477?lang=en_us&edition=fundamental","pubTime":"2026-01-21 08:04","pubTimestamp":1768953887,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nFWN3YL1A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4110","ACR"],"gpt_icon":0},{"id":"2604181359","title":"Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2604181359","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604181359?lang=en_us&edition=fundamental","pubTime":"2026-01-17 01:00","pubTimestamp":1768582800,"startTime":"0","endTime":"0","summary":"Designation based on clinical evidence supporting potential of ianalumab in Sjgren’s disease, including phase III trials1Distinction expedites development and review of treatments for serious conditio","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/16/3220482/0/en/Novartis-ianalumab-receives-FDA-Breakthrough-Therapy-designation-for-Sj%C3%B6gren-s-disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR","BK4110"],"gpt_icon":0},{"id":"2603400937","title":"Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs","url":"https://stock-news.laohu8.com/highlight/detail?id=2603400937","media":"prnewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603400937?lang=en_us&edition=fundamental","pubTime":"2026-01-16 09:00","pubTimestamp":1768525200,"startTime":"0","endTime":"0","summary":"SHANGHAI and HONG KONG, Jan. 16, 2026 /PRNewswire/ -- Antengene Corporation Limited , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines forautoimmune disease, solid tumors and hematological malignancies indications, announced that it recently presented at the 44th Annual J.P. Morgan Healthcare Conference held in San Francisco. At the conference, Antengene shared the latest data and clinical development plans for its core clinical asset, ATG-022 , as well as R&D progress on ATG-125 , its steric hindrance masking AnTenGager T cell engager  platform, and other key preclinical programs.Advancing clinical development across 1L to 3L gastric cancer: Antengene is currently conducting the Phase I/II CLINCH study and","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/antengene-presents-at-jpm-strong-clinical-data-update-and-strategic-focus-on-next-generation-adcs-and-tces-302662555.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417517546.SGD","LU0868494617.USD","ACR","LU1084165304.USD","LU2756315664.SGD","ACR.AU","LU2106854487.HKD","LU2430703095.HKD","BK4581","LU0345770308.USD","LU1974910355.USD","IE00BFXG1179.USD","LU0170899867.USD","LU2264538146.SGD","IE00BHPRN162.USD","IE00B3S45H60.SGD","CRS.AU","LU1064131342.USD","LU0820562030.AUD","LU2023250843.SGD","ORR","LU1244550494.USD","BK4534","LU0211328371.USD","LU0106831901.USD","LU0345769631.USD","IND.AU","LU1629891620.HKD","LU0683600562.USD","LU0208291251.USD","IE00BN8TJ469.HKD","CRS","IE00BKVL7J92.USD","LU0943347566.SGD","IND","IE0034235188.USD","LU1670627923.USD","LU0820561818.USD","LU2746668461.USD","ORR.AU","IE0034235295.USD","BK7508","LU0251132253.USD","LU0787776722.HKD","CR","LU2065731478.USD","LU0106261372.USD","LU0006306889.USD","LU0345770993.USD"],"gpt_icon":0},{"id":"2602439177","title":"Focused Clinical Strategy and Accelerated Approval Path for ACR-368 in High-Need Serous Endometrial Cancer Underpin ACRV Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2602439177","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602439177?lang=en_us&edition=fundamental","pubTime":"2026-01-09 01:35","pubTimestamp":1767893734,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on Acrivon Therapeutics, Inc. today and set a price target of $19.00. Emily Bodnar has...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/focused-clinical-strategy-and-accelerated-approval-path-for-acr-368-in-high-need-serous-endometrial-cancer-underpin-acrv-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/focused-clinical-strategy-and-accelerated-approval-path-for-acr-368-in-high-need-serous-endometrial-cancer-underpin-acrv-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACRV","ACR"],"gpt_icon":0},{"id":"2601364536","title":"Acrivon Highlights Promising ACR-368 Phase 2b Endometrial Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2601364536","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601364536?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:59","pubTimestamp":1767877156,"startTime":"0","endTime":"0","summary":"Acrivon Therapeutics, Inc. ( ($ACRV) ) just unveiled an update. On January 8, 2026, Acrivon Therapeutics reported updated Phase 2b data for its CHK...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/acrivon-highlights-promising-acr-368-phase-2b-endometrial-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/acrivon-highlights-promising-acr-368-phase-2b-endometrial-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4110","ACR"],"gpt_icon":0},{"id":"2601361831","title":"Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11","url":"https://stock-news.laohu8.com/highlight/detail?id=2601361831","media":"GlobeNewswire","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601361831?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:30","pubTimestamp":1767875400,"startTime":"0","endTime":"0","summary":"Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in OncoSignature-positive (BM+) subjects with endometrial cancer (EC) showed 39% overall","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/08/3215277/0/en/Acrivon-Therapeutics-Announces-Positive-ACR-368-Phase-2b-Endometrial-Cancer-Clinical-Data-with-EU-Expansion-to-Accelerate-Enrollment-Initial-ACR-2316-Clinical-Data-and-ACR-6840-its.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORR","BK4539","AAQC","BK4201","LENZ","EC","BK4156","MSS","ACR","BK4110","BK4113","BK4007","EDC"],"gpt_icon":0},{"id":"2601744892","title":"Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates via Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2601744892","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601744892?lang=en_us&edition=fundamental","pubTime":"2026-01-06 20:30","pubTimestamp":1767702600,"startTime":"0","endTime":"0","summary":"Company to host conference call and webcast at 8:30 a.m. ET on Thursday, January 8, 2026WATERTOWN, Mass., Jan.  06, 2026  (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/06/3213504/0/en/Acrivon-Therapeutics-to-Announce-Clinical-Update-on-its-Ongoing-Phase-2b-Studies-and-Planned-Confirmatory-Phase-3-Trial-for-ACR-368-Initial-Clinical-Data-on-ACR-2316-and-Other-AP3-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ACR","BK4139","BK4110","BK4539","BK4007"],"gpt_icon":0},{"id":"2592926282","title":"TÜV Rheinland Reinforces Global Contamination Control with Clean Room Validation Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2592926282","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592926282?lang=en_us&edition=fundamental","pubTime":"2025-12-18 11:30","pubTimestamp":1766028600,"startTime":"0","endTime":"0","summary":"Clean rooms are engineered environments designed to tightly control airborne particles, microbial contamination, temperature, humidity and airflow. Their performance directly influences product safety, research accuracy and regulatory compliance. From vaccine production to semiconductor fabrication, even minor deviations can result in compromised output, financial losses or failed audits.Airflow Visualisation Studies to assess air movement and detect turbulence.Airborne Particle Count Testing for classification and monitoring compliance.HEPA/ULPA Filter Integrity Testing to verify filtration performance.Air Change Rate  and Ventilation Performance evaluations to ensure consistent environmental control.Recovery Time Testing to determine how quickly cleanliness levels are restored.Temperature and Humidity Mapping to confirm environmental stability.Microbial Sampling and Testing for aseptic and high-risk environments.","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2845451/Clean_Room__Validation.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2845451/Clean_Room__Validation.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/tuv-rheinland-reinforces-global-contamination-control-with-clean-room-validation-services-302642175.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4110","BK7096","ACR.AU","BK7508","ACR"],"gpt_icon":0},{"id":"2592979199","title":"Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2592979199","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592979199?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:30","pubTimestamp":1765974600,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., Dec.  17, 2025  (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/17/3206904/0/en/Acrivon-Therapeutics-to-Announce-Clinical-Update-on-its-Ongoing-Phase-2b-Studies-and-Planned-Confirmatory-Phase-3-Trial-for-ACR-368-Initial-Clinical-Data-on-ACR-2316-and-Other-AP3-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR","BK4110","BK4007","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2591662482","title":"Press Release: ACRES Commercial Realty Corp. Declares Quarterly Cash Dividends for its Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2591662482","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591662482?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:10","pubTimestamp":1765833000,"startTime":"0","endTime":"0","summary":"UNIONDALE, N.Y., Dec. 15, 2025 /PRNewswire/ -- ACRES Commercial Realty Corp.   announced today that its Board of Directors declared cash dividends on its Preferred Stock.The Company will pay a cash dividend on its 8.625% Fixed-to-Floating Series C Cumulative Redeemable Preferred Stock  in the amount of $0.6103331 per share, which reflects a rate of 9.76533%, equal to three-month Term SOFR on the dividend determination date plus a spread of 5.927% per annum. The dividend will be payable on January 30, 2026, to holders of record on January 2, 2026.The Company will also pay a cash dividend on its 7.875% Series D Cumulative Redeemable Preferred Stock in the amount of $0.4921875 per share. The dividend will be payable on January 30, 2026, to holders of record on January 2, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR","BK4110"],"gpt_icon":0},{"id":"2590287346","title":"Novartis ianalumab significantly extends disease control in patients with immune thrombocytopenia with only four once-monthly doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2590287346","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590287346?lang=en_us&edition=fundamental","pubTime":"2025-12-09 20:30","pubTimestamp":1765283400,"startTime":"0","endTime":"0","summary":"Ianalumab (9 mg/kg) plus eltrombopag extended ITP disease control by 45% with patients maintaining disease control 2.8 times longer than with placebo plus eltrombopag1,2 62% of patients treated with i","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/09/3202247/0/en/Novartis-ianalumab-significantly-extends-disease-control-in-patients-with-immune-thrombocytopenia-with-only-four-once-monthly-doses.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ITP","BK4110","LU2463526074.USD","SLE","BK4077","BK4109","ACR","ASH","BK4199"],"gpt_icon":0},{"id":"2584906256","title":"Antengene Hosts 2025 R&D Day Showcasing Encouraging Clinical Data and Solid Progress with Investigational Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2584906256","media":"prnewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584906256?lang=en_us&edition=fundamental","pubTime":"2025-11-20 10:56","pubTimestamp":1763607360,"startTime":"0","endTime":"0","summary":"SHANGHAI and HONG KONG, Nov. 20, 2025 /PRNewswire/ -- Antengene Corporation Limited , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, announced that at the R&D Day taking place today, it will present the latest data and future plans for three mid/late-stage clinical programs, including ATG-022 , ATG-037 , and ATG-101 . The company will also share the latest progress on ATG-125 :A B7H3 x PD-L1 targeted therapy featuring\"IO + ADC\"dual-effect molecules for the treatment of solid tumors and its AnTenGagerT-cell engager  technology platform which incorporates steric hindrance masking, along with updates on several key preclinical programs.In addition, guest expert Prof. Xin Wang, Chief Physician, Drug Clinical Trial Center, National Cancer Center / Cancer Hospital of the Chinese Academy of Medica","market":"hk","thumbnail":"https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/antengene-hosts-2025-rd-day-showcasing-encouraging-clinical-data-and-solid-progress-with-investigational-programs-302621100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B66KJ199.SGD","LU2065731478.USD","ORR","IE0031619046.USD","BK4110","CRS","BK7508","BK4161","ACR","BK4097","BK4187","IND.AU","BK7096","ACR.AU","IE00B7SZL793.SGD","ORR.AU","CR","PRGS","LU2065732104.USD","CRS.AU","BK4006","IE00B19Z4B17.USD","LU0963586101.USD","BK7095"],"gpt_icon":0},{"id":"2583966185","title":"Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2583966185","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583966185?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:30","pubTimestamp":1763040600,"startTime":"0","endTime":"0","summary":"Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient Enrollment of FT819, an Off-the-Shelf CD19-targeted CAR T-cell Product Candidate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/13/3187342/24675/en/Fate-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Business-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRC","ASH","EMA","BK4230","BK4081","BK4077","BK4109","BK4213","IE0031619046.USD","LU2463526074.USD","LU0963586101.USD","IE00B66KJ199.SGD","CRS","BK4156","BK4528","IE00B19Z4B17.USD","BK4233","IE00B7SZL793.SGD","BK4205","BK4006","LU0266512127.USD","ACR","LU0456854461.SGD","LU2065731478.USD","CAR","IIM","BK4139","BK4022","FATE","SLE","BK4110","BK4187","UK"],"gpt_icon":0},{"id":"2581762102","title":"Anaptys Announces Third Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2581762102","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581762102?lang=en_us&edition=fundamental","pubTime":"2025-11-05 05:15","pubTimestamp":1762290900,"startTime":"0","endTime":"0","summary":"Announced intent to separate biopharma operations from substantial royalty assets by YE 2026Phase 2 top-line data through Week 12 for rosnilimab, a pathogenic T cell depleter, in ulcerative colitis on","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/04/3180905/0/en/Anaptys-Announces-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR","BK4110","BK4144","BK4590","GPP","TEP"],"gpt_icon":0},{"id":"2580644330","title":"ACRES Commercial Realty Corp. Reports Positive Q3 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2580644330","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580644330?lang=en_us&edition=fundamental","pubTime":"2025-11-01 08:29","pubTimestamp":1761956977,"startTime":"0","endTime":"0","summary":"Acres Commercial Realty Corp. (($ACR)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for ACR...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/acres-commercial-realty-corp-reports-positive-q3-earnings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/acres-commercial-realty-corp-reports-positive-q3-earnings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACR"],"gpt_icon":0},{"id":"2579464089","title":"Acres Commercial Realty Is Maintained at Market Outperform by Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2579464089","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579464089?lang=en_us&edition=fundamental","pubTime":"2025-10-31 20:57","pubTimestamp":1761915420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 31, 2025 08:57 ET (12:57 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR","BK4110"],"gpt_icon":0},{"id":"2579452037","title":"ACRES Commercial Realty Corp. price target raised to $24.50 from $23.50 at Citizens JMP","url":"https://stock-news.laohu8.com/highlight/detail?id=2579452037","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579452037?lang=en_us&edition=fundamental","pubTime":"2025-10-31 18:05","pubTimestamp":1761905152,"startTime":"0","endTime":"0","summary":"Citizens JMP raised the firm’s price target on ACRES Commercial Realty Corp. (ACR) to $24.50 from $23.50 and keeps an Outperform rating on the shar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acres-commercial-realty-corp-price-target-raised-to-24-50-from-23-50-at-citizens-jmp-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acres-commercial-realty-corp-price-target-raised-to-24-50-from-23-50-at-citizens-jmp-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACR","JMP"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":63,"code":"91000000","status":"200"}]}}